Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.1730
H.R.1730: Cancer Drug Parity Act of 2019
About This Bill
- This bill was introduced in the 116th Congress
- This bill is primarily about health
- Introduced March 13, 2019
- Latest Major Action March 14, 2019
- See the one similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
170 (105 Democrats, 65 Republicans)
Bill Version
- Introduced in House - March 13, 2019
Bill Summary
Cancer Drug Parity Act of 2019 This bill requires health plans that cover anticancer medications administered by a health care provider to provide no less favorable cost sharing for patient-administered anticancer medications. This requirement applies to medications that are (1) approved by the Food and Drug Administration; (2) medically necessary for the cancer treatment; and (3) clinically appropriate in terms of type, frequency, extent...
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
Date | Description |
---|---|
March 14, 2019 |
Referred to the Subcommittee on Health.
|
March 13, 2019 |
Referred to the House Committee on Energy and Commerce.
|
March 13, 2019 |
Introduced in the House by Brian Higgins (D-N.Y.) |